Skip to main content
. 2015 Jul 29;10:4763–4781. doi: 10.2147/IJN.S75101

Figure 4.

Figure 4

Biocompatibility of PCL/MD nanocarrier.

Notes: (A) Effect of blank nanocarrier on the cell viability of normal prostate epithelial cell line WPE1-NA22 (n≥3). (B) Cell viability (mean ± SD) of all three cell lines DU145, PC3, and LNCaP after 24 hrs of treatment with increasing nanocarrier concentration (n≥3).

Abbreviations: PCL, polycaprolactone; MD, maltodextrin; SD, standard deviation; hrs, hours; DMSO, dimethyl sulfoxide.